ROLE OF THE HOSPITAL PHARMACIST IN THE MANAGEMENT OF DRUGS NOT ADAPTED TO PATIENTS WITH DYSPHAGIA
4CPS-215
THE TRUTH ABOUT MEDICATION RECONCILIATION DOCUMENTATION
4CPS-209
A CLINICAL PHARMACIST-LED MEDICATION RECONCILIATION SERVICE IN GERIATRIC PATIENTS UPON ADMISSION TO HOSPITAL
4CPS-208
EXPERIENCE OF IMPLEMENTATION OF A CLINICAL PHARMACY SERVICE IN A FIRST-LEVEL HOSPITAL IN PORTUGAL
4CPS-194
DESCRIPTIVE ANALYSIS OF ACTIVE CLINICAL TRIALS MANAGED IN A PHARMACY DEPARTMENT OF A TERTIARY HOSPITAL
4CPS-192
HE STRUCTURES, PROCESSES AND RELATED OUTCOMES OF CLINICAL PHARMACY PRACTICE AS PART OF THE MULTIDISCIPLINARY CARE OF PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW
4CPS-187
EFFECT OF RANIBIZUMAB IN VISION-RELATED QUALITY OF LIFE IN PATIENTS DIAGNOSED WITH RETINAL PATHOLOGY
4CPS-186
VISION-RELATED QUALITY OF LIFE IN PATIENTS DIAGNOSED WITH RETINAL PATHOLOGY
4CPS-183
OFF-LABEL RITUXIMAB IN NEUROLOGY PATIENTS
4CPS-170
EVALUATION OF ZOLEDRONIC ACID IN THE TREATMENT OF BONE DISEASES WITH HIGH RISK OF FRACTURES
4CPS-161
DETERMINATION OF DRUG SERUM LEVELS TO OPTIMISE TREATMENT OF PATIENTS WITH PSORIASIS
4CPS-153
CASE REPORT: PAEDIATRIC PATIENT WITH RECURRENT APHTHOUS STOMATITIS TREATED WITH THALIDOMIDE
4CPS-149
TIME OF PERMANENCE IN SECOND OR SUCCESSIVE LINES OF TREATMENT WITH ANTI-TNF DRUGS VS OTHER BIOLOGICAL DRUGS IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES
4CPS-144
EFFECTIVENESS AND SAFETY OF INDUCTION THERAPY WITH VEDOLIZUMAB IN PATIENTS WITH INTESTINAL INFLAMMATORY DISEASE
4CPS-140
EFFECTIVENESS OF TOCILIZUMAB IN A TAKAYASU ARTERITIS PAEDIATRIC PATIENT: A CASE REPORT
